Idera Announces Publication of Studies on Chemistry of Novel Antagonists for Toll-like Receptors 7 and 9
News Jan 07, 2009
Idera Pharmaceuticals, Inc. has announced the publication of studies on the chemistry of novel compounds that have been shown to act as antagonists for Toll-like Receptors (TLR) 7 and 9. These antagonist candidates have potential application in autoimmune and inflammatory diseases.
The paper entitled “Oligodeoxyribonucleotide-Based Antagonists for Toll-Like Receptors 7 and 9” is published in the Journal of Medicinal Chemistry and is authored by Daqing Wang, Ph.D., Lakshmi Bhagat, Ph.D., Dong Yu, Ph.D., Fu-Gang Zhu, Ph.D., Jimmy Tang, M.S., Ekambar Kandimalla, Ph.D., and Sudhir Agrawal, D.Phil., all of Idera.
“These novel antagonist candidates have been created through our ongoing structure-activity relationship studies of oligonucleotides, through which we have also identified agonists of TLR7, 8 and 9,” said Sudhir Agrawal, D.Phil., Chief Executive Officer and Chief Scientific Officer. “We have evaluated selected antagonist candidates in preclinical models of lupus, rheumatoid arthritis, multiple sclerosis, psoriasis, and colitis, and studies continue in additional preclinical models of autoimmune and inflammatory diseases.”
“Based on encouraging results in preclinical models, we are conducting preclinical development studies with our lead TLR antagonist drug candidate, IMO-3100, for an intended Investigational New Drug application,” said Tim Sullivan, Ph.D., Vice President of Development Programs.
“Members of our Autoimmune Disease Scientific Advisory Board are assisting us in the clinical development strategy for IMO-3100 and other antagonist candidates in autoimmune and inflammatory diseases,” Sullivan added.
New Chemical Synthesis Process: Synergy of Two Catalysts in One FlaskNews
Researchers report the one-step synthesis of a ketone from an aldehyde by the combination of thiazolium N-heterocyclic carbene and palladium/bisphosphine catalysts in one flask. The two catalysts function in a synergistic manner. This study is expected to lead to new synthesis processes of precursor compounds for medications.READ MORE
Comments | 0 ADD COMMENT
World Congress on Advanced Pharmacy and Clinical Research
Jul 16 - Jul 17, 2018
11th International Conference and Exhibition on Metabolomics & Systems Biology
May 17 - May 19, 2018
6th Annual Congress on Biology and Medicine of Molecules
Sep 17 - Sep 18, 2018